134 related articles for article (PubMed ID: 3305213)
1. Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.
Schaison G; Leverger G; Bancillon A; Marty M; Olive D; Cornu G; Griscelli C; Lemerle S; Harousseau JL; Bonnet M
Haematol Blood Transfus; 1987; 30():461-5. PubMed ID: 3305213
[No Abstract] [Full Text] [Related]
2. [Evaluation of two methods of maintenance chemotherapy with methotrexate and 6-mercaptopurine for childhood acute lymphoblastic leukemia].
Kawai S; Fujimoto T; Hiyoshi Y; Nibu K; Ito M; Kadoya S; Shingaki Y
Rinsho Ketsueki; 1984 Jun; 25(6):819-26. PubMed ID: 6384569
[No Abstract] [Full Text] [Related]
3. Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia.
Lauer SJ; Pinkel D; Buchanan GR; Sartain P; Cornet JM; Krance R; Borella LD; Casper JT; Kun LE; Hoffman RG
Cancer; 1987 Nov; 60(10):2366-71. PubMed ID: 3499211
[TBL] [Abstract][Full Text] [Related]
4. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
[TBL] [Abstract][Full Text] [Related]
5. High-dose cytosine arabinoside with amsacrine for treatment of acute lymphoblastic leukemia.
Arlin ZA
J Clin Oncol; 1986 Dec; 4(12):1868. PubMed ID: 3465878
[No Abstract] [Full Text] [Related]
6. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M
Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798
[TBL] [Abstract][Full Text] [Related]
7. Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and consolidation therapies (preliminary results of EORTC Study 58791).
Stryckmans P; Marie JP; Suciu S; Solbu G; Debusscher L; Bury J; Peetermans M; Andrien JM; Fière D; Cauchie C
Haematol Blood Transfus; 1987; 30():130-6. PubMed ID: 3305190
[No Abstract] [Full Text] [Related]
8. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
van Eys J; Berry D; Crist W; Doering E; Fernbach D; Pullen J; Shuster J; Wharam M
Cancer; 1989 Jan; 63(1):23-9. PubMed ID: 2910421
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
[TBL] [Abstract][Full Text] [Related]
10. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: better in the evening.
Rivard GE; Infante-Rivard C; Hoyoux C; Champagne J
Lancet; 1985 Dec; 2(8467):1264-6. PubMed ID: 2866334
[TBL] [Abstract][Full Text] [Related]
11. Short-term high-dose treatment in bad-risk ALL and lymphoblastic NHL.
Willemze R; Peters WG; Colly LP
Br J Haematol; 1987 Apr; 65(4):501-2. PubMed ID: 3472590
[No Abstract] [Full Text] [Related]
12. Chemotherapy of childhood acute lymphoblastic leukemia.
Bell BA; Whitehead VM
Dev Pharmacol Ther; 1986; 9(3):145-70. PubMed ID: 3519131
[TBL] [Abstract][Full Text] [Related]
13. Intensive treatment of acute leukemia in adults 70 years of age and older.
Walters RS; Kantarjian HM; Keating MJ; Estey EH; McCredie KB; Freireich EJ
Cancer; 1987 Jul; 60(2):149-55. PubMed ID: 3474052
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group.
Miller DR; Leikin S; Albo V; Sather H; Karon M; Hammond D
Cancer; 1983 Mar; 51(6):1041-9. PubMed ID: 6336986
[No Abstract] [Full Text] [Related]
15. Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.
Ghaddar HM; Pierce S; Kantarjian HM; Freireich EJ; Keating MJ; Estey EH
Leuk Lymphoma; 1996 Jun; 22(1-2):71-6. PubMed ID: 8724530
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of childhood acute lymphoblastic leukemia: efficacy of intermittent pulses of 6-mercaptopurine and methotrexate for maintenance chemotherapy, CCLSG-S811 (phase III study). Children's Cancer and Leukemia Study Group].
Koizumi S; Fujimoto T; Takeda T; Yatabe M; Katou K; Kaneko A; Sekine I; Takeshita T; Utsumi J; Kubota H
Rinsho Ketsueki; 1987 Aug; 28(8):1375-84. PubMed ID: 3323563
[No Abstract] [Full Text] [Related]
17. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
[No Abstract] [Full Text] [Related]
18. Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia.
Stryckmans P; De Witte T; Bitar N; Marie JP; Suciu S; Solbu G; Debusscher L; Bury J; Peetermans M; Andrien JM
Semin Oncol; 1987 Jun; 14(2 Suppl 1):67-72. PubMed ID: 3296209
[TBL] [Abstract][Full Text] [Related]
19. Risk groups in a multicenter pilot study for treatment of acute lymphoblastic and acute undifferentiated leukemia in adults.
Hoelzer D; Thiel E; Löffler H; Bodenstein H; Büchner T; Engelhardt R; Ganser A; Messerer D; Rühl H; Zwingers T
Haematol Blood Transfus; 1985; 29():48-50. PubMed ID: 3861487
[No Abstract] [Full Text] [Related]
20. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
